Výsledky vyhledávání - "Diana, Altshuler"

The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome

Autor: Alyson Katz, Diana Altshuler, John Papadopoulos, Nancy Amoroso, Ronald Goldenberg, Elizabeth Tarras, Kelsey Krolikowski, Jacklyn Hagedorn, David Fridman, Xian Jie Cindy Chen, Eduardo Iturrate, Shari B. Brosnahan

Publikováno v: Annals of Pharmacotherapy. 57:5-15

Background: Corticosteroids and tocilizumab have been shown to improve survival in patients who require supplemental oxygen from coronavirus disease 2019 (COVID-19) pneumonia. The optimal dose of immunosuppression for the treatment of COVID-19 acute

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e44a4e5aaf060fe4e88e60e669e7fcb
https://doi.org/10.1177/10600280221094571

Zobrazit plný text záznamu

Antithrombotic management for Impella® temporary ventricular assist devices: An analysis of an academic health-system experience

Autor: Olivia Iskaros, Tania Ahuja, Serena Arnouk, Bridget Toy, Tyler Lewis, Diana Altshuler, Deane Smith, John Papadopoulos, Cristian Merchan

Publikováno v: The International Journal of Artificial Organs. 45:550-559

The use of acute mechanical circulatory support (MCS) has increased over the last decade. For patients with left-ventricular failure, an Impella® (Abiomed, Danvers, MA) may be used to improve cardiac output. The purpose of this study is to describe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11fd23824a3b988753d859e896068808
https://doi.org/10.1177/03913988221082686

Zobrazit plný text záznamu

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection

Autor: Scott Schoninger, Yanina Dubrovskaya, Kassandra Marsh, Diana Altshuler, Prithiv Prasad, Eddie Louie, Scott Weisenberg, Sarah Hochman, David Fridman, Polina Trachuk

Publikováno v: Open Forum Infectious Diseases. 9

Background Patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) have poor outcomes and frequently develop comorbid conditions, including cytomegalovirus (CMV) reactivation. The implications of CMV reactivation i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0f4346e649bda323b7180e7d34de62
https://doi.org/10.1093/ofid/ofac286

Zobrazit plný text záznamu

Akademický článek

Refractory Toxic Shock-Like Syndrome from Streptococcus dysgalactiae ssp. equisimilis and Intravenous Immunoglobulin as Salvage Therapy: A Case Series

Autor: Marjan Islam, Dennis Karter, Jerry Altshuler, Diana Altshuler, David Schwartz, Gianluca Torregrossa

Publikováno v: Case Reports in Infectious Diseases, Vol 2016 (2016)

Infections from Streptococcus dysgalactiae ssp. equisimilis (SDSE) can cause a wide variety of infections, ranging from mild cellulitis to invasive disease, such as endocarditis and streptococcal toxic shock-like syndrome (TSLS). Despite prompt and a

Externí odkaz: https://doaj.org/article/a908863491b349c5bd41455b0bd8ca7b

Zobrazit plný text záznamu

Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support

Autor: Serena Arnouk, Bridget Toy, Tyler C Lewis, Diana Altshuler, Bishoy Zakhary, John Papadopoulos, Deane E. Smith, Cristian Merchan

Publikováno v: ASAIO Journal. 66:300-306

The approach to monitoring anticoagulation in adult patients receiving heparin on extracorporeal membrane oxygenation (ECMO) support is controversial. The objective of this study was to compare the correlation between anti-Xa and activated partial th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc140d02583b8e28c734efc19fdbfe4
https://doi.org/10.1097/mat.0000000000001004

Zobrazit plný text záznamu

The incidence of propofol infusion syndrome in critically-ill patients

Autor: Wai Kin, Li, Xian Jie Cindy, Chen, Diana, Altshuler, Shahidul, Islam, Peter, Spiegler, Liane, Emerson, Michael, Bender

Publikováno v: Journal of Critical Care. 71:154098

PRIS is a potentially fatal syndrome characterized by various clinical symptoms and abnormalities. Experts suggest that propofol treatment duration ≥48 h or dose ≥83 μg/kg/min is associated with developing PRIS. We hypothesized PRIS might be und

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbefe20ee1fda40ee196f797cdd98c8
https://doi.org/10.1016/j.jcrc.2022.154098

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání